SCHEMBL287199

SCHEMBL287199

COc1ccnc(Cl)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29792641 1.00 — —
Pyridine SCHEMBL28222133 0.89 CCR1 (0.50) —
SCHEMBL191463 0.87 SMN1; SMN2 (0.50) —
SCHEMBL191885 0.86 CCR1 (0.47) —
SCHEMBL15832082 0.80 TRPA1 (0.50) —
SCHEMBL30864880 0.80 GRM5 (0.48) —
SCHEMBL26099232 0.80 APP (0.51) —
SCHEMBL27314075 0.80 GRM5 (0.48) —
SCHEMBL27032950 0.79 RECQL (0.41) —
SCHEMBL17930597 0.79 DYRK1A (0.59) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 530 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113754579-A Preparation method of pyridine derivative 正大天晴药业集团股份有限公司 2021-12-07 — — CN claimed
CN-110813201-B Concentrated palladium colloid and preparation method and application thereof 苏州天承化工有限公司 2021-09-28 — — CN claimed
CN-111116460-A Synthesis method of 2-chloro-4-hydroxypyridine-3-formaldehyde hydrobromide 阿里生物新材料(常州)有限公司 2020-05-08 — — CN claimed
CN-110813201-A Concentrated palladium colloid and preparation method and application thereof 苏州天承化工有限公司 2020-02-21 — — CN claimed
CN-106751439-A Carbinol-modified pnenolic aldehyde foam material of a kind of 2 aminopyridine 4 and preparation method thereof 沈阳化工大学 2017-05-31 — — CN claimed
CN-103664766-B Preparation method of 2-aminopyridine-4-methyl alcohol UNIV ZHEJIANG 2015-06-24 — — CN claimed
CN-103664766-A Preparation method of 2-aminopyridine-4-methyl alcohol UNIV ZHEJIANG 2014-03-26 — — CN claimed
US-12636290-B2 BET inhibitors for modulating DUX4 expression in FSHD SAINT LOUIS UNIVERSITY (US) 2026-05-26 — — US disclosed
EP-4741018-A2 SULPHONAMIDE COMPOUNDS Anaxis Pharma Pty Ltd (AU) 2026-05-13 — — EP disclosed
EP-4142732-B1 METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS GLOBAL BLOOD THERAPEUTICS INC (US) 2026-04-22 — — EP disclosed
US-20260027096-A1 PHD INHIBITORS UNIV OXFORD INNOVATION LTD (GB) 2026-01-29 — — US disclosed
US-20250388593-A1 CEREBLON E3 LIGASE BINDING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PRODUCTION METHOD THEREFOR MITSUBISHI TANABE PHARMA CORPORATION (JP) 2025-12-25 — — US disclosed
EP-4655294-A1 PYRAZOLE DERIVSTIVES AS PHD INHIBITORS Oxford University Innovation Limited (GB) 2025-12-03 — — EP disclosed
WO-2002036570-A1 4-SUBSTITUTED QUINOLINES AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2002-05-10 — — WO disclosed
WO-2002004447-A1 VARIOLIN DERIVATIVES AS ANTI-CANCER AGENTS PHARMA MAR, S.A. (ES) 2002-01-17 — — WO disclosed
EP-1124821-A1 COMPOUNDS AstraZeneca AB (SE) 2001-08-22 — — EP disclosed
WO-2000027842-A1 COMPOUNDS ASTRAZENECA AB (SE) 2000-05-18 — — WO disclosed
US-5811540-A 5-O-pyrimidyl-2,3-dideoxy-1-thiofuranoside derivative, and production method and use thereof THE NOGUCHI INSTITUTE (JP) 1998-09-22 — — US disclosed
US-4472409-A ANTIULCER AGENTS BYK GULDEN LOMBERG CHEMISCHE FABRIK GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-09-18 — — US disclosed
EP-0080602-A1 Substituted benzimidazoles, process for their preparation, their use and medicaments containing them Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1983-06-08 — — EP disclosed
Send feedback